|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02450279 |
|
Date of registration:
|
18/05/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Scintigraphic Comparison of Lung Deposition With Two Nebulizers During Invasive Mechanical Ventilation
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
March 2016 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT02450279 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Pierre-François Laterre |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Head of Intensive Care Unit, Cliniques Universitaires Saint-Luc |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Invasive mechanical ventilation
- Healthy lungs
Exclusion Criteria:
- Discontinued procedure due to adverse events.
Age minimum:
18 Years
Age maximum:
90 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Post-operative Neurosurgery
|
|
Intervention(s)
|
|
Device: Vibrating-mesh nebulizer
|
|
Drug: technetium-99m - Diethylenetriaminepentaacetic acid
|
|
Other: Preoperative spirometry
|
|
Device: Jet Nebulizer
|
|
Other: Planar scintigraphy
|
|
Primary Outcome(s)
|
|
Pulmonary deposition
[Time Frame: Immediately after nebulization by imaging assessment, an expected average of 30 minutes]
|
|
Secondary Outcome(s)
|
|
Lung function
[Time Frame: Preoperative assessment, the day before inclusion]
|
|
Mechanical ventilation settings
[Time Frame: During nebulisation time, an expected average of 15 minutes]
|
|
Penetration index
[Time Frame: Immediately after nebulization by imaging assessment, an expected average of 30 minutes]
|
|
Secondary ID(s)
|
|
AeroVent-02
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|